Zomedica Corp (ZOM)
0.1203
0.00 (0.00%)
USD |
NYAM |
Nov 05, 11:36
Zomedica Enterprise Value: 40.25M for Nov. 4, 2024
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 04, 2024 | 40.25M |
| November 01, 2024 | 40.45M |
| October 31, 2024 | 40.45M |
| October 30, 2024 | 41.04M |
| October 29, 2024 | 41.44M |
| October 28, 2024 | 43.34M |
| October 25, 2024 | 41.14M |
| October 24, 2024 | 39.95M |
| October 23, 2024 | 40.55M |
| October 22, 2024 | 43.54M |
| October 21, 2024 | 44.64M |
| October 18, 2024 | 43.54M |
| October 17, 2024 | 44.84M |
| October 16, 2024 | 50.23M |
| October 15, 2024 | 44.54M |
| October 14, 2024 | 47.23M |
| October 11, 2024 | 49.83M |
| October 10, 2024 | 50.03M |
| October 09, 2024 | 50.52M |
| October 08, 2024 | 51.12M |
| October 07, 2024 | 52.12M |
| October 04, 2024 | 58.21M |
| October 03, 2024 | 50.23M |
| October 02, 2024 | 50.62M |
| October 01, 2024 | 50.23M |
| Date | Value |
|---|---|
| September 30, 2024 | 57.41M |
| September 27, 2024 | 52.72M |
| September 26, 2024 | 51.72M |
| September 25, 2024 | 50.43M |
| September 24, 2024 | 48.63M |
| September 23, 2024 | 47.83M |
| September 20, 2024 | 56.41M |
| September 19, 2024 | 50.23M |
| September 18, 2024 | 47.73M |
| September 17, 2024 | 51.32M |
| September 16, 2024 | 50.23M |
| September 13, 2024 | 52.32M |
| September 12, 2024 | 52.72M |
| September 11, 2024 | 47.33M |
| September 10, 2024 | 47.03M |
| September 09, 2024 | 48.13M |
| September 06, 2024 | 47.03M |
| September 05, 2024 | 47.93M |
| September 04, 2024 | 43.44M |
| September 03, 2024 | 44.84M |
| August 30, 2024 | 49.13M |
| August 29, 2024 | 46.73M |
| August 28, 2024 | 46.33M |
| August 27, 2024 | 48.33M |
| August 26, 2024 | 51.52M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
-2.280M
Minimum
Nov 02 2020
2.421B
Maximum
Feb 11 2021
176.85M
Average
69.24M
Median
Jul 24 2020
Enterprise Value Benchmarks
| Standard BioTools Inc | 468.31M |
| Ainos Inc | 9.488M |
| LENSAR Inc | 53.81M |
| Intelligent Bio Solutions Inc | 0.0571M |
| Adagio Medical Holdings Inc | 23.48M |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -23.93M |
| Revenue (Quarterly) | 6.131M |
| Total Expenses (Quarterly) | 15.17M |
| EPS Diluted (Quarterly) | -0.024 |
| Gross Profit Margin (Quarterly) | 71.15% |
| Profit Margin (Quarterly) | -390.3% |
| Earnings Yield | -47.38% |
| Normalized Earnings Yield | -25.90 |